This trial is testing whether a less invasive way of removing lymph nodes from people with breast cancer is just as effective as the standard method.
- Breast Cancer
1 Primary · 5 Secondary · Reporting Duration: Up to 3 weeks
Awards & Highlights
1 Treatment Group
Targeted Axillary Dissection (TAD)
1 of 1
45 Total Participants · 1 Treatment Group
Primary Treatment: Axillary Dissection · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this trial offer opportunities to participate at the moment?
"Clinicaltrials.gov states that this research study is actively seeking participants, which was first publicised on March 1st 2022 and recently modified on the 23rd of the same month." - Anonymous Online Contributor
What is the sample size of participants for this research project?
"That is correct. According to clinicaltrials.gov, this medical trial was posted on the 1st of March 2022 and has since been re-opened for recruitment with an update occurring on the 23rd of March. 45 candidates are being sought at one particular site." - Anonymous Online Contributor